Does IRBESARTAN Cause Haemoglobin decreased? 46 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Haemoglobin decreased have been filed in association with IRBESARTAN (Irbesartan). This represents 0.5% of all adverse event reports for IRBESARTAN.
46
Reports of Haemoglobin decreased with IRBESARTAN
0.5%
of all IRBESARTAN reports
2
Deaths
29
Hospitalizations
How Dangerous Is Haemoglobin decreased From IRBESARTAN?
Of the 46 reports, 2 (4.3%) resulted in death, 29 (63.0%) required hospitalization, and 6 (13.0%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which IRBESARTAN Alternatives Have Lower Haemoglobin decreased Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE